ii. opioid receptor agonists
  iii. opioid receptor antagonists
chapter 18  central stimulants
  i. cerebral stimulants
  ii. medullary stimulants
chapter 19  drugs used in the treatment of heart failure
  i. pathophysiology of congestive heart failure
  ii. diuretics
  lii. aldosterone antagonists
  iv. inhibitors of raas: acei and at1 receptor antagonists
  v. β adrenergic receptor blocking agents
  vi. vasodilators
  vii. cardiac glycosides
  vs. [3 adrenergic receptor stimulators
  ix. phosphodiesterase inhibitors
chapter 20  antihypertensive drugs
  |. introduction
  ii. drugs that alter sodium and water balance
  ill. drugs that alter sympathetic nervous system function
  iv. vasodilators
  v. drugs that interfere with the renin-angiotensin system
  vi. clinical pharmacology of antihypertensive drugs
chapter 21  anti-angina pectoris drugs
  i. introduction
  ii. nitrates and nitrites
  iii. calcium channel blockers
  iv. /3 receptor antagonists
chapter 22  antiarrhythmic drugs
  i. introduction
  ii. class i a
  iii. class i b
  iv. class i c
  v. class ii
  vi. class iii
  vii. class iv
  viii. others
chapter 23  autihyperlipidemic drugs
  i. atherogenesis
  ii. lipoprotein transport
  iii. dyslipidaemia
  iv. antihyperlipidemic drugs
chapter 24  diuretic and dehydrant drugs
  i. kidney structure and function
  ii. diuretics
  iii. osmotic diuretics (mannitol, sorbitol, glucose, urea)
chapter 25  antiasthmatie drugs
  i. bronchodilators
  ii. anti-inflammatory drugs
chapter 26  drugs used in gastrointestinal diseases
  i. drugs used to treat peptic ulcer
  1i. antiemetic drugs
  iii. antidiarrheal drugs
  iv. laxatives.
chapter 27  drugs affecting uterine motility
  i. drugs that stimulate uterine contraction
  ii. drugs that inhibit uterine contraction
chapter 28  anticoagulants and coagulants
  i. introduction
  ii. anticoagulants
  iii. antiplatelet drugs
  iv. fibrinolytic drugs
  v. coagulants
chapter 29  histamine and antihistamine drugs
  i. histamine
  ii. h1 receptor antagonists
  iii. h2 receptor antagonists
chapter 30 adrenocorticosteroids
  i. introduction
  ii. glucocorticoids
  iii. mineralocorticoids
chapter 31  drugs affecting the thyroid gland
  i . thyroid hormone (th)
  ii. antithyroid drugs
chapter 32  antidiabetic drugs
  i. insulin
  ii. oral hypoglycemic drugs
  iii. current treatment options
chapter 33  introduction to antibacterial drugs
  i. specialty terms
  h. antimicrobial mechanisms
  iii. mechanism of resistance to antibiotics
chapter 34  syntheticantimicrobial drugs
  i. sulfonamides
  ii. trimethoprim
  iii. quinolones
chapter 35  β-lactam antibiotics
  i. penicillins
  ii. cephalosporins
  iii. other β-lactam drugs
chapter 36  macrolides, lincosamides and glycopeptides
  i. macrolides
  ii. lincosamides
  iii. glycopeptides
chapter 37  broad-spectrum antibiotics
  i. tetracyclines
  ii. chloramphenicols
chapter 38  aminoglycosides and polypeptides
  i. aminoglycosides
  ii. polypeptides
chapter 39  antifungal drugs
  i. antibiotics
  ii. azole antifungal drugs
  11i. allylamine antifungal drugs
  iv. pyrimidine antifungal drugs
chapter 40  antiviral drugs
  i. anti-human immunodeficiency virus drugs
  ii. anti-herpersvirus drugs
  iii. anti-influenza drugs
  iv. anti-hepacivirus drugs
chapter 41  antimycobacterial drugs
  i. introduction
  ii. first-line drugs used in tuberculosis
  iii. alternative second-line drugs in treatment of tuberculosis
  iv. combination chemotherapy of tuberculosis
chapter 42  antimalarial drugs
  i. plasmodium life cycles and action of antimalarial drugs
  ii. antimalarial drugs mainly applied to control symptoms
  iii. antimalarial drugs mainly applied to control relapse and transmission
  iv. antimalarial drugs mainly applied to causal prophylaxis
chapter 43  amebicides

 2/3   首页 上一页 1 2 3 下一页 尾页

教材 研究生/本科/专科教材 医学

在线阅读